BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioMidwest

  Data Presented At ICE/ENDO 2014 Shows MicroBiome Therapeutics LLC’ NM504 Improves Blood Glucose Control In Diabetes And Prediabetes

  June 23, 2014

   · 

  4 min read
• Deals

  To Fend Off Pfizer Inc., AstraZeneca PLC Contemplating Sale Of Some Future Revenue From Existing Drugs

  June 23, 2014

   · 

  1 min read
• Biotech Bay

  ScinoPharm Selects ValGenesis, Inc. VLMS 3.0 To Manage Validation Lifecycle Processes

  June 23, 2014

   · 

  3 min read
• Drug Development

  Positive New Phase 3a Data On Novo Nordisk A/S’s Liraglutide

  June 23, 2014

   · 

  5 min read
• Deals

  Questcor Pharmaceuticals, Inc. (Headquarters) Closes Transaction To Acquire International Rights To Synacthen® And Synacthen® Depot

  June 23, 2014

   · 

  4 min read
• Business

  ProBioGen AG Signs GlymaxX ADCC Enhancement Technology License Deal

  June 23, 2014

   · 

  3 min read
• Business

  Aratana Therapeutics Adds Robert P. Roche, Jr. To Board Of Directors

  June 23, 2014

   · 

  2 min read
• Business

  Summit Corporation Appoints Erik Ostrowski As Chief Financial Officer

  June 23, 2014

   · 

  3 min read
• Policy

  Smith & Nephew Inc. Halts U.S. Renasys™ Sales Amid FDA Snafu

  June 23, 2014

   · 

  3 min read
• Drug Development

  Aradigm Corporation Announces The Dosing Of The First Patient In Phase III Study Of Pulmaquin In Non-Cystic Fibrosis Bronchiectasis (ORBIT-4)

  June 23, 2014

   · 

  1 min read